These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11086634

  • 1. Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data.
    Mallion JM, Badguet JP.
    J Hum Hypertens; 2000 Oct; 14 Suppl 2():S33-41. PubMed ID: 11086634
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P, Adler G, Brandt-Eliasson U, Karp L, Ohlson K, Renberg L, Sjöquist PO, Abrahamsson T.
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
    Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S75-80. PubMed ID: 10076925
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
    Unger T.
    Am J Cardiol; 1999 Nov 18; 84(10A):9S-15S. PubMed ID: 10588089
    [Abstract] [Full Text] [Related]

  • 6. Candesartan cilexetil: an angiotensin II-receptor blocker.
    See S, Stirling AL.
    Am J Health Syst Pharm; 2000 Apr 15; 57(8):739-46. PubMed ID: 10786259
    [Abstract] [Full Text] [Related]

  • 7. Newly emerging pharmacologic differences in angiotensin II receptor blockers.
    Oparil S.
    Am J Hypertens; 2000 Jan 15; 13(1 Pt 2):18S-24S. PubMed ID: 10678284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.
    Unger T, Azizi M, Belz GG.
    J Hum Hypertens; 2000 Oct 15; 14 Suppl 2():S23-31. PubMed ID: 11086633
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y, Asmar R.
    Am J Hypertens; 1999 Dec 15; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep 15; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 12. Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.
    Sever PS.
    J Hum Hypertens; 1999 Jan 15; 13 Suppl 1():S3-10; discussion S33-4. PubMed ID: 10076915
    [Abstract] [Full Text] [Related]

  • 13. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G, Fuchs W.
    Curr Med Res Opin; 2005 Jun 15; 21(6):935-40. PubMed ID: 15969893
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improving antihypertensive efficacy while maintaining placebo-like tolerability.
    Sever PS.
    Blood Press Suppl; 2000 Jun 15; 1():19-22. PubMed ID: 11059631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH.
    J Hum Hypertens; 2000 Apr 15; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.